Evidence map›Paper›PMID 40204828›Full record

ArticleScientific reports2025

Synovial macrophages drive severe joint destruction in established rheumatoid arthritis.

Dengfeng Wu, Yiping Huang, Jun Zhao, Wei Long, Bihua Wang, Yan Wang, Haili Chen, Rui Wu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. TRPM2 is a direct pain transducer.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. SynovialInternational journal of molecular sciences · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dengfeng Wu *Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, 330006, Jiangxi, China.
Yiping Huang *Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, 330006, Jiangxi, China.
Jun ZhaoDepartment of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, 330006, Jiangxi, China.
Wei LongDepartment of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, 330006, Jiangxi, China.
Bihua WangDepartment of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, 330006, Jiangxi, China.
Yan WangDepartment of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, 330006, Jiangxi, China.
Haili ChenDepartment of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, 330006, Jiangxi, China.
Rui WuDepartment of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, 330006, Jiangxi, China. ndyfy00400@ncu.edu.cn.

Funding

National Natural Science foundation of China 82260898
6 · The paper itself

Abstract

To investigate the synovial pathological predictors associated with the progression to severe bone erosion in patients with established rheumatoid arthritis (RA). This retrospective study analyzed 41 active RA patients with a disease duration of more than 24 months at our center between March and December 2023. All of these patients underwent synovial biopsy to obtain synovial tissue. These patients were divided into two groups (mild group and severe group) based on the severity of bone erosion assessed by plain X-ray. HE and immunohistochemical staining for CD3, CD20, CD68, and CD138 were conducted on synovium. Stained cells positive for these markers were observed under microscope. the number of positive cells per 20× high-power field in the sublining layer was recorded for each marker. The mild group consisted of 25 patients (23 females) with a median age of 58 years and a median disease duration of 114 months. The severe group included 16 patients (13 females) with a median age of 56 years and a median disease duration of 120 months. There were no significant differences between the mild and severe groups in terms of age, gender, disease duration, RF, ACPA, ESR, and CRP (P > 0.05). However, the disease activity score in 28 joints (DAS-28) of severe group were significantly higher than mild group (5.16 vs. 4.53, P = 0.010). Inflammatory infiltration score observed with HE staining was significantly higher in severe group (P = 0.033), whereas synovial hyperplasia, neovascularization, and stromal activation did not show significant differences between the two groups. The results of immunohistochemistry revealed significantly higher expression of synovial CD68-positive cells in severe group. Multivariable logistic regression analysis showed that synovial CD68-positive cells (OR = 1.020, P = 0.011) were independent risk factors for progressive bone erosion in RA. Synovial macrophage infiltration is an independent risk factor leading to severe progression of bone erosion in RA.

Indexed as

Arthritis, RheumatoidJointsMacrophagesSynovial MembraneAdultAgedDisease ProgressionFemaleHumansMaleMiddle AgedRetrospective StudiesSeverity of Illness IndexBone erosionMacrophagesRheumatoid arthritisSynovial biopsy

Identifiers

PMID40204828
PMCPMC11982296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.